A surge in the number of medical device makers and the complexity of their products has spurred the FDA to launch a new initiative just to track them. The Medical Device Postmarket Transformation Initiative, an offshoot of the Center for Devices and Radiological Health, will allow the FDA to alert the public more quickly when problems occur.

Full Story:

Related Summaries